ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation.
Shannen J DeconinckChristoph NixSvenja BarthEveline Bennek-SchöppingAntoine RauchAn-Sofie SchelpeElien RooseHendrik B FeysInge PareynAline VandenbulckeJoshua MuiaChristophe VandenbrieleSophie SusenBart MeynsClaudia TersteegSteven JacobsSimon F De MeyerKaren VanhoorelbekePublished in: Journal of thrombosis and haemostasis : JTH (2022)
Hence, inhibition of ADAMTS13 could become a novel therapeutic strategy to manage aVWS in MCS device patients.